International Biotechnology (IBT) Stock Chart & Stock Price History GBX 636 -6.00 (-0.93%) As of 08/1/2025 12:24 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock International Biotechnology Stock Price Performance The International Biotechnology (IBT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 5.36%, with a year-to-date return of -6.74%. In the past month, the stock has increased 8.53%, reflecting recent market activity. As of the latest close, International Biotechnology traded at GBX 636 with a market cap of £228.46 million and volume of 145,234 shares. Five years ago, the stock traded at GBX 732, representing a 13.11% decrease over that period. At the time, it had a market cap of £280.88 million and a volume of 39,435 shares. Receive IBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.32%1 Month Performance+8.53%3 Month Performance+0.95%Year-To-Date Performance-6.74%1 Year Performance-5.36%5 Year Performance-13.11% IBT Stock Chart for Sunday, August, 3, 2025 IBT Chart by TradingView International Biotechnology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025GBX 642GBX 636-0.93%GBX 638GBX 626145,234 shs£228.46 million07/31/2025GBX 640GBX 642+0.31%GBX 648.79GBX 637.83105,324 shs£230.62 million07/30/2025GBX 634GBX 640+0.95%GBX 650GBX 636167,706 shs£229.90 million07/29/2025GBX 644GBX 634-1.55%GBX 642GBX 63288,442 shs£227.74 million07/28/2025GBX 642GBX 644+0.31%GBX 652GBX 64054,213 shs£231.33 million07/25/2025GBX 636GBX 642+0.94%GBX 643.16GBX 634105,253 shs£230.62 million07/24/2025GBX 656GBX 636-3.05%GBX 644GBX 63691,812 shs£228.46 million07/23/2025GBX 640GBX 656+2.50%GBX 656GBX 636142,754 shs£235.64 million07/22/2025GBX 642GBX 640-0.31%GBX 648GBX 63588,882 shs£229.90 million07/21/2025GBX 658GBX 642-2.43%GBX 651.27GBX 64286,922 shs£230.62 million Get the Latest News and Ratings for IBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025GBX 656GBX 658+0.30%GBX 658.20GBX 65093,293 shs£236.36 million07/17/2025GBX 640GBX 656+2.50%GBX 659.01GBX 64038,557 shs£235.64 million07/16/2025GBX 636GBX 640+0.63%GBX 650GBX 627.12134,455 shs£229.90 million07/15/2025GBX 640GBX 636-0.63%GBX 652GBX 632168,188 shs£228.46 million07/14/2025GBX 632GBX 640+1.27%GBX 644.99GBX 63455,283 shs£229.90 million07/11/2025GBX 626GBX 632+0.96%GBX 638.12GBX 630207,604 shs£227.02 million07/10/2025GBX 614.40GBX 626+1.89%GBX 632GBX 615240,274 shs£224.87 million07/09/2025GBX 598GBX 614.40+2.74%GBX 618.20GBX 594.62202,319 shs£220.70 million07/08/2025GBX 584GBX 598+2.40%GBX 602GBX 587.0178,760 shs£214.81 million07/07/2025GBX 586GBX 584-0.34%GBX 602GBX 58470,414 shs£209.78 million07/04/2025GBX 586GBX 586GBX 602GBX 58679,731 shs£210.50 million07/03/2025GBX 594GBX 586-1.35%GBX 602GBX 58679,731 shs£210.50 million07/02/2025GBX 586GBX 594+1.37%GBX 598GBX 586432,488 shs£213.37 million Related Companies Ruffer Investment Stock Chart Scottish American Investment Stock Chart Capital Gearing Stock Chart Murray Income Trust Stock Chart Standard Life Private Equity Trust Stock Chart The European Smaller Companies Trust Stock Chart Blue Star Capital Stock Chart Schroder Investment Trust - Schroder AsiaPacific Fund Stock Chart TwentyFour Income Stock Chart NB Private Equity Partners Stock Chart Receive IBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (LON:IBT) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.